Program: Monitoring insecticide resistance in Bactrocera oleae populations
Authors: Chrysargyris Antonios, Varikou Kiriaki, Karataraki Aggeliki, Katsikogiannis Georgios, Pitika Evanthia, Sidiropoulos Nikolaos, Vontas John, Vitiniotou A., Simoglou K.
Publication: 2013
Pests: Bactrocera oleae
Substances: dimethoate, alpha-cypermethrin, spinosad




Active ingredient: alpha-cypermethrin - Bioassay method: topical bioassay DR test     
POPULATIONYEARnED5095%CL-ED50RFRF50%mortality_abbott_corrected
Lab strain (ref) 1987 130 0.3 0.14–0.46 1
AgiosNIkolaos08-1 2008 53 1.7 0.68-4.31 6
AgiosNikolaos08-2 2008 62 3.6 2.49-5.4 12
ΑgiosNikolaos09-2 2009 103 2.60 1.60-4.30 9
AgiosNikolaos10-01 2010 112 3.8 2.8-5.2 12
AgiosNikolaos12-01 2012 101 0.587 1.8
Chania08-6 2008 116 2.5 1.67-3.47 8
Chania08-1 2008 144 3.4 0.99-11.49 11
Chania08-3-4 2008 174 4.4 1.31-14.73 15
Chania09-2 2009 112 2.20 1.50-3.40 7
Chania09-1 2009 116 3.60 1.50-8.60 12
Chania08-5 2008 124 3.4 0.21-55.35 11
Chania10-02 2010 96 2.2 1.4-8.6 7
Chania10-07 2010 112 2.3 1.6-3.3 8
Mitilini08-6 2008 85 3.6 1.26–10.26 12
Mitilini09-1 2009 93 1.50 0.77-2.30 5
Samos08-1 2008 40 3.9 2.56-6.21 13
Fokida09-3 2010 36 0.55 0.05-1.10 2
Samos09-3 2009 92 0.76 0.44-1.20 3
Heraklion09-4 2009 95 1.40 0.92-2.20 5
Sitia09-1 2009 101 4.40 2.10-6.70 15
Sitia10-01 2010 112 3.7 2.2-6.5 12



Active ingredient: alpha-cypermethrin - Bioassay method: topical bioassay DT     
POPULATIONYEARnED5095%CL-ED50RFRF50%mortality_abbott_corrected
AgiosNikolaos13-01 2013 20 60
Chania12-01 2012 14 86
Chania12-02 2012 24 87.5
Samos10-03 2010 28 100
Samos12-01 2012 10 100
Samos13 2013 7 100
Fokida10 2010 20 100
Heraklion12-01 2012 10 100
Heraklion13-01 2013 20 65
AgiosNikolaos12-02 2012 20 85
Mitilini10 2010 20 100
Mitilini12-01 2012 12 100
Mitilini13-01 2013 6 100



Active ingredient: dimethoate - Bioassay method: topical bioassay DR test     
POPULATIONYEARnED5095%CL-ED50RFRF50%mortality_abbott_corrected
Lab strain (ref) 1987 122 3.3 2.04–4.77 1
AgiosNikolaos08-2 2008 127 24.2 1.46–47.17 7
AgiosNIkolaos08-1 2008 61 53.0 17.17–157.78 16
AgiosNIkolaos09-1 2009 94 13.0 6.7-21.6 4
AgiosNikolaos10-01 2010 112 36.6 21.0-64.0 11
Chania08-1 2008 174 39.6 25.24-63.75 12
Chania08-6 2008 144 152.3 105.75-216.71 47
Chania08-3-4 2008 102 155.1 89.34-429.42 48
Chania09-2 2009 95 15.2 5.9-38.8 5
Chania09-1 2009 95 62.3 34.6-95.8 19
Chania10-04 2010 112 13.0 9.2-18.3 4
Chania08-5 2008 147 82.1 54.28-120.42 25
Chania10-07 2010 112 12.9 9.4-17.7 4
Mitilini08-6 2008 54 98.9 62.45–155.47 30
Mitilini09-1 2009 68 41.6 28.5-62.0 13
Samos08-1 2008 61 100.4 66.85-147.97 31
Samos09-1 2009 67 26.7 12.8-48.5 8
Fokida09-3 2010 24 38.0 11.3-280 12
Heraklion09-7 2009 108 62.5 43.3-89.9 19
Heraklion10-03 2010 112 50.3 34.7-74.7 15
Sitia09-1 2009 96 77.5 54.3-108 23
Sitia10-01 2010 96 65.9 47.0-92.7 20



Active ingredient: spinosad - Bioassay method: topical bioassay DR test     
POPULATIONYEARnED5095%CL-ED50RFRF50%mortality_abbott_corrected
Lab strain (ref) 1987 117 3.6 2.19-5.42 1
Chania08-1 2008 165 9.6 5.99-15.25 3
Chania08-3-4 2008 70 35.6 19.61-86.00 10
Chania09-1 2009 107 8.2 4.9-13.6 2
Chania09-2 2009 108 10.0 5.7-15.8 3
Mitilini08-6 2008 98 15.1 9.14–24.14 4
Mitilini08-6 2008 138 15.1 9.14–24.14 4
Mitilini09-1 2009 64 22.3 9.8-34.1 6
Chania08-5 2008 137 15.3 5.12-45.05 4
Chania10-07 2010 112 7.4 5.0-10.9 2
Chania10-03 2010 96 11.0 7.5-16.2 3
AgiosNikolaos08-2 2008 91 19.9 11.30-35.86 6
AgiosNIkolaos08-1 2008 91 20.6 10.57–38.26 6
AgiosNIkolaos09-1 2009 103 2.6 1.3-4.1 1
AgiosNikolaos10-01 2010 112 7.4 5.2-10.5 2
Samos08-1 2008 44 25.9 17.25-39.12 7
Samos09-1 2009 101 16.0 7.6-25.1 4
Fokida09-3 2010 24 9.7 0.50-2154 3
Sitia09-1 2009 102 13.2 7.2-22.3 4
Sitia10-01 2010 112 10.0 6.9-14.4 3
Heraklion09-5 2009 109 13.8 8.3-23.8 4
Rethimno09-2 2009 106 21.3 9.8-39.8 6
Rethimno10-02 2010 96 6.6 3.8-11.4 2
Heraklion10-04 2010 112 9.5 6.1-15.1 3
Mitilini12-01 2012 18 14.8 7



Active ingredient: spinosad - Bioassay method: topical bioassay DT     
POPULATIONYEARnED5095%CL-ED50RFRF50%mortality_abbott_corrected
Samos10-03 2010 28 100
Fokida10 2010 20 100
Mitilini10 2010 20 100



Table of descriptions
ref
Reference sample
n
Number of samples
ED50
Ηalf maximal Effective Dose
95CL-ED50
Confidence limits for ED50
RF
Resistant factor
RF50
Resistance Factor (that kills the 50% of the sample)
mortality_abbott_corrected
Percentage of mortality (Abbott corrected)
Version 0.28.020817-alpha
This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES. Investing in knowledge society through the European Social Fund.
espa
We acknowledge support of this work by the project "Advanced Research Activities in Biomedical and Agro alimentary Technologies" (MIS 5002469) which is implemented under the "Action for the Strategic Development on the Research and Technological Sector", funded by the Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014- 2020) and co-financed by Greece and the European Union (European Regional Development Fund).
espa
Location
Substance
Pest
Searching ...